Adverse Drug Reactions of Antihypertensives and CYP3A5*3 Polymorphism Among Chronic Kidney Disease Patients

Adverse Drug Reactions of Antihypertensives and CYP3A5*3 Polymorphism Among Chronic Kidney Disease Patients

Chronic kidney disease (CKD) patients may be more susceptible to adverse drug reactions (ADRs), given their complex medication regimen and altered physiological state driven by a decline in kidney function. This study aimed to describe the relationship between CYP3A5*3 polymorphism and the ADR of an...

Full description

Bibliographic Details
Main Authors: Fei Yee Lee, Farida Islahudin, Abdul Halim Abdul Gafor, Hin-Seng Wong, Sunita Bavanandan, Shamin Mohd Saffian, Adyani Md Redzuan, Mohd Makmor-Bakry
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Pharmacology
Subjects:
adverse drug reaction
chronic kidney disease
pharmacogenetics
CYP3A5
antihypertensive drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.848804/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.848804/full

Similar Items